BK MONTREAL CD 2/ CA0636711016 /
04/06/2024 08:00:23 | Var. -0.72 | Volume | Denaro21:55:27 | Lettera21:55:27 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
81.12EUR | -0.88% | 0 Fatturato: 0.00 |
80.56Quantità in denaro: 400 | 80.72Quantità in lettera: 400 | 58.08 bill.EUR | - | - |
GlobeNewswire
22:10
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
GlobeNewswire
22:05
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
GlobeNewswire
22:05
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:05
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
GlobeNewswire
22:05
Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja Ca...
GlobeNewswire
22:05
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
GlobeNewswire
22:05
HashiCorp and AWS sign strategic collaboration agreement to expand joint product and go-to-market in...
GlobeNewswire
22:05
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment o...
GlobeNewswire
22:05
Sportsman’s Warehouse Holdings, Inc. Announces First Quarter 2024 Financial Results
GlobeNewswire
22:05
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
Newsfile Corp
22:02
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cambium Networks Corporation Investors to Secure Counsel...
GlobeNewswire
22:01
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:01
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)